Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thorough QT study with recommended and supratherapeutic doses of tolterodine.

Clinical pharmacology and therapeutics - 1 Mar 2007

Malhotra B K, Glue P, Sweeney K, Anziano R, Mancuso J, Wicker P

Abstract excerpt

The objective of our study was to determine the QTc effects of tolterodine. A crossover-design thorough QT study of recommended (2 mg twice daily) and supratherapeutic (4 mg twice daily) doses of tolterodine, moxifloxacin (400 mg once daily), and placebo was performed. Electrocardiograms (ECGs) and pharmacokinetic samples were obtained on days 1-4; time-matched baseline ECGs were taken on day 0. Mean...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aza Compounds
Share to Benzhydryl Compounds
Share to Cresols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Over Studies

Share to Fluoroquinolones

Share to Moxifloxacin

Share to Muscarinic Antagonists

Share to Quinolines

Source

Identifiers

PMID: 17339867
DOI: 10.1038/sj.clpt.6100089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thorough QT study with recommended and supratherapeutic doses of tolterodine.PMID 17339867Read ↗

Virtual Thorough QT (TQT) Trial-Extrapolation of In Vitro Cardiac Safety Data to In Vivo Situation Using Multi-Scale Physiologically Based Ventricular Cell-wall Model Exemplified with Tolterodine and Fesoterodine.Semantic proximity Read ↗

Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control.Semantic proximity Read ↗

Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration‐QTc RelationshipsSemantic proximity Read ↗

Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers.Semantic proximity Read ↗

Preclinical QT safety assessment: Cross-species comparisons and human translation from an industry consortiumSemantic proximity Read ↗

QT and QTc interval with standard and supratherapeutic doses of darifenacin, a muscarinic M3 selective receptor antagonist for the treatment of overactive bladder.Semantic proximity Read ↗

CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation.Semantic proximity Read ↗

A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.Semantic proximity Read ↗

Assessment of Interspecies Differences in Drug-Induced QTc Interval Prolongation in Cynomolgus Monkeys, Dogs and HumansSemantic proximity Read ↗

Drug-induced long QT syndrome.Semantic proximity Read ↗

Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity.Semantic proximity Read ↗

The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.